ClinicalTrials.gg
TerminatedNCT04011202Updated Dec 5, 2022

Virtual Reality, Mood, and Sedentary Behaviour After Stroke

An interventional study of Virtual reality gaming program (VR-gaming program) in Stroke, Stroke, Ischemic and Stroke Hemorrhagic, sponsored by University of British Columbia. Terminated at 1 site in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2022-12-05.

Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment

Why this study was terminated
Due to COVID-19; lack of recruitment; staff turnover.
Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

The purpose of this study is to: 1) evaluate the feasibility (e.g. recruitment and retention, administrative and participant burden) of a VR program to improve mood and sedentary behaviour in inpatient stroke survivors; and 2) develop an understanding of the effects of VR on mood and sedentary behaviours among inpatient stroke survivors.

Read the detailed description

It is common for individuals who have had a stroke to have deficits in motor and sensory function, communication, and cognition. These deficits pose serious barriers for stroke survivors to effectively manage their health and well-being over time, and has contributed to excessive amounts of sedentary time beginning in inpatient rehabilitation, and continuing post-discharge.

Sedentary behaviours are associated with various health risks. Lying down, sitting for prolonged periods of time, or any other activity with an energy expenditure of ≤1.5 metabolic equivalent units are associated with an increased incident of chronic diseases, as well as with reduced physical function, and increased symptoms of depression and frailty. Moreover, sedentary behaviours are associated with all-cause mortality, with each additional hour spent sedentary increasing mortality risk. Thus, efforts to reduce sedentary time as inpatients may be a promising therapeutic intervention to improve longer term health outcomes of stroke survivors.

Issues with mood after stroke are common. After stroke, depression and depressive symptoms are common occurrences with as many as 28% experiencing depressive disorders or symptoms one month post-stroke, and 36% between two and five months. Similarly, anxiety symptoms and psychological stress are prevalent issues, with 23% reporting anxiety within five months post stroke, and 25% experiencing psychological stress. Not only are these issues associated with reduced quality of life, poorer functional outcomes after rehabilitation, increased healthcare use, and mortality, these psychological factors have also been shown to be associated with sedentary behaviour. It is therefore plausible that decreases in sedentary behaviours may be achieved via mood improvements.

Virtual reality (VR) has garnered substantial attention as a cost-effective treatment approach in stroke rehabilitation, particularly as a means to supplement existing therapy. While the use of VR in stroke rehabilitation has resulted in positive outcomes, the outcomes studied have primarily focused on physical and functional rehabilitation. Despite evidence that VR is emerging as a method to address issues with mood, the use of VR to improve mood among inpatient stroke survivors has yet to be studied.

Objectives: In this research, the investigators will: 1) evaluate the feasibility (e.g. recruitment and retention, administrative and participant burden) of a VR program to improve mood and sedentary behaviour in inpatient stroke survivors; and 2) develop an understanding of the effects of VR on mood and sedentary behaviours among inpatient stroke survivors.

Hypotheses: The investigators expect the protocol will demonstrate sufficient feasibility to support a subsequent larger randomized controlled trial (RCT). The investigators also hypothesize that the VR program will improve the primary endpoints, measures of mood, in people with stroke receiving inpatient rehabilitation, and that such improvements will reduce sedentary behaviour.

This 1-year feasibility study will use a parallel group, single-blinded (tester), randomized controlled trial that will be registered and adhere to the CONSORT guidelines. Eligible participants will be randomly assigned (1:1) to either: 1) Intervention: 3 times per week to discharge of VR-gaming; or 2) Control: usual care.

02

Conditions studied

  • Stroke
  • Stroke, Ischemic
  • Stroke Hemorrhagic
  • Stroke, Lacunar

Keywords

  • Stroke
  • Virtual reality
  • Depressive symptoms
  • Sedentary behaviour
03

In context

Stroke

7,441 studies on the registry are indexed under Stroke; 2,012 are open to participants now.

This study's enrollment of 28 is below the median of 50 across 5,482 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University of British Columbia is the lead sponsor of 1,335 studies on the registry; 256 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Have had a stroke (confirmed by CT scan or MRI); are an inpatient receiving stroke rehabilitation for an expected length of stay of 14 days or longer; are at least 19 years of age or older; are able to provide informed consent; have clearance from a physician to participate in the study; are able to understand English.

Exclusion criteria

Exclusion Criteria:

  • Have a visual or hearing impairment; have a planned surgical intervention; are not medically stable; have a significant musculoskeletal or other neurological condition; severe aphasia.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
28 participants (actual)

Study arms

  • Experimental
    VR Group

    Receives the VR protocol

    Behavioral: Virtual reality gaming program (VR-gaming program)

  • No intervention
    Control Group

    Receives regular care

Interventions

  • BehavioralVirtual reality gaming program (VR-gaming program)

    Participants in the VR-gaming program will receive three 20-30 minutes sessions of VR-gaming per week for the duration of their inpatient stay. Participants will select VR games/program in categories of: Relaxation; Leisure sport and activities; or Action/adventure. The VR-gaming program will be implemented one-on-one, face-to-face by a clinician using the commercially-available Oculus Go system.

06

What researchers measure

Primary outcomes

  1. Depressive symptoms

    The 7-item Depression scale in the Hospital Anxiety and Depression Scale; total sub scale scores range from 0 to 21; higher values indicate more depressive symptoms

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

Secondary outcomes

  1. Anxiety symptoms

    The 7-item Anxiety scale in the Hospital Anxiety and Depression Scale; total sub scale scores range from 0 to 21; higher values indicate more anxiety symptoms

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

  2. Stress

    10-item Perceived Stress Scale; total scores range from 0 to 40; higher values indicate higher perceived stress

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

  3. Motivation

    16-item Situational Motivation Scale, including 4 sub scales: 4-item Instrinsic motivation; 4-item Identified regulation; 4-item External motivation; 4-item Amotivation; Mean sub scale scores are derived, ranging from 1 to 7; higher values indicate higher motivation for each sub scale

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

  4. Happiness

    4-item Subjective Happiness Scale; Mean scores range from 1 to 7; higher values indicate higher happiness

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

  5. Stroke severity (functional disability)

    6-category Modified Ranking Scale; individuals are categorized into one of six categories, ranging from 'no disability = 0' to 'severe disability = 5'. A higher category ranking is indicative of greater disability

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

  6. Sedentary time

    7-item Measure of Older Adults' Sedentary Time; for each item (i.e., sedentary behaviour (e.g., watching tv)), participants estimate the amount of time in that activity in hours and minutes for the past week; total time is summed for an estimated sedentary behaviour for the past week

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

Other outcomes

  1. Feasibility indicator - recruitment rate

    Number of participants recruited per week

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

  2. Feasibility indicator - retention rate

    Number of participants that complete the study, relative to the number that started the study

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

  3. Feasibility indicator - perceived benefit of the VR Training Program,

    17-item study specific Satisfaction survey; Mean scores range from 1 to 5; Higher scores indicate greater satisfaction

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

  4. Feasibility indicators - treatment fidelity

    Percentage of participants that participate in ALL VR Training sessions

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

  5. Feasibility indicators - participant and tester burden

    Percentage of participants that complete a data collection session in 60 minutes or less

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

  6. Feasibility indicators - trainer burden

    Time spent administering each VR session

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

  7. Feasibility indicators - ease of using equipment

    Downtime due to technical difficulties

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

  8. Feasibility indicators - safety

    Number of adverse events due to the VR Training program

    Time frame: Rehabilitation discharge (generally 4-6 weeks)

07

Study locations

1 site
  • Kelowna General Hospital
    Kelowna, British Columbia V1Y 1T2, Canada
08

References and documents

Publications

  • Rash I, Helgason M, Jansons D, Mitchell L, Sakakibara BM. The influence of a virtual reality entertainment program on depressive symptoms and sedentary behaviour in inpatient stroke survivors: a research protocol for a pilot randomized controlled trial. Pilot Feasibility Stud. 2022 Oct 22;8(1):230. doi: 10.1186/s40814-022-01189-8. PubMed 36273223 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2019 to primary completion in Apr 2022, 32 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 3, 2019
First posted
Jul 8, 2019
StartActual
Aug 21, 2019
Primary completionActual
Apr 30, 2022
CompletionActual
Apr 30, 2022
Last update
Dec 5, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 5, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04011202
Responsible party
Brodie Sakakibara (Assistant Professor, University of British Columbia) — Principal investigator
First posted
Jul 8, 2019
Start date
Aug 21, 2019
Primary completion
Apr 30, 2022
Completion
Apr 30, 2022
Last update
Dec 5, 2022

Study contacts

Brodie Sakakibara
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion